GHS-R Activators are a collection of chemical compounds that directly or indirectly enhance the functional activity of the Growth Hormone Secretagogue Receptor (GHS-R) through various biochemical mechanisms. Compounds like MK-0677, Capromorelin, Anamorelin, Macimorelin, and Relamorelin function as synthetic ghrelin mimetics, directly binding to and activating the GHS-R, which in turn stimulates the release of growth hormone, a critical regulator of growth, metabolism, and energy homeostasis.
Other activators such as Ibipinabant, CP 464709-6, Tabimorelin, SM-130,686, GHRP-6, Examorelin, and L-692,429 also target GHS-R but may do so in a slightly different context. Ibipinabant, although primarily interacting with cannabinoid pathways, has been noted to indirectly affect GHS-R pathways, suggesting a potential cross-talk between cannabinoid signaling and ghrelin-mediated growth hormone release. The synthetic molecules like CP 464709-6 and L-692,429, despite being non-peptidyl, still possess the ability to enhance GHS-R activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anamorelin | 249921-19-5 | sc-480157 | 10 mg | $260.00 | ||
Anamorelin is a synthetic agonist of GHS-R that mimics ghrelin, thereby stimulating growth hormone release and having an anabolic effect by promoting muscle growth pathways mediated by GHS-R activation. | ||||||